Capstone Investment Advisors’s Immunomedics Inc IMMU Stock Holding History

Capstone Investment Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20,000	Closed	-$277K	–	1482
2019 Q2	$277K	Sell	20,000 -24,600	-55%	-$370K	﹤0.01%	1212
2019 Q1	$857K	Buy	+44,600	New	+$719K	0.01%	862

Capstone Investment Advisors's IMMU Position: Q4 2020 in Review

Capstone Investment Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 850,800 shares — an estimated $72.3M sold.

Capstone Investment Advisors first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $72.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Capstone Investment Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Capstone Investment Advisors sold 850,800 Immunomedics Inc shares in Q4 2020, an estimated $72.3M.
Capstone Investment Advisors first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Capstone Investment Advisors's Immunomedics Inc position peaked at $72.3M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Capstone Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.